Business
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of
About this update from Heartbeam, Inc.
[{"type":"text","content":" SANTA CLARA, Calif.--(BUSINESS WIRE)--\nHeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, will hold a conference call on Wednesday March 20, 2024 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full fiscal year ended December 31, 2023, and will be providing regulatory updates, reviewing ongoing initiatives, and anticipated 2024 milestones. A press release detailing these results will be issued prior to the call.\n\n\nHeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno, Consulting CFO Richard Brounstein, and VP of Regulatory Affairs Deborah Castillo, PhD, will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.\n\n\nTo access the call, please use the following information:\n\n\n\n\nDate:\n\n\n\n\n\n\nWednesday March 20, 2024\n\n\n\n\n\n\n\n\nTime:\n\n\n\n\n\n\n4:30 p.m. Eastern time (1:30 p.m. Pacific time)\n\n\n\n\n\n\n\n\nDial-in:\n\n\n\n\n\n\n1-877-704-4453\n\n\n\n\n\n\n\n\nInternational Dial-in:\n\n\n\n\n\n\n1-201-389-0920\n\n\n\n\n\n\n\n\nConference Code:\n\n\n\n\n\n\n13743963\n\n\n\n\n\n\n\n\nWebcast:\n\n\n\n\n\n\nhttps://viavid.webcasts.com/starthere.jsp?ei=1652944&tp_key=9699aa7d39\n\n\n\n\n\n\n\nA telephone replay will be available approximately three hours after the call and will run through June 20, 2024, by dialing 1-844-512-2921 from the U.S., or 1-412-317-6671 from international locations, and entering replay pin number: 13743963. The replay can also be viewed through the webcast link above and the presentation utilized during the call will be available in the company’s investor relations section here.\n\n\nAbout HeartBeam, Inc.\n\n\nHeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company that is dedicated to transforming cardiac care through the power of personalized insights. The company’s proprietary vectorelectrocardiography (VECG) technology collects 3D signals of the heart’s electrical activity and converts them into a 12-lead ECG. This platform technology is designed to be used on portable, patient-friendly devices such as a credit-card sized monitor, watch or patch. Physicians...